- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01612455
Linking Infectious and Narcology Care in Russia (LINC)
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The objective of this study "Linking Infectious and Narcology Care (LINC)" is to improve upon the treat and retain dimensions of the "seek, test, treat, and retain" paradigm in Eastern Europe. We will implement and assess a behavioral and structural intervention in Russia designed to support and motivate HIV-infected narcology heroin dependent patients (i.e., IDUs) to engage (i.e., initiate and retain) in HIV medical care and ultimately improve their HIV outcomes.
LINC is a clinical model designed to coordinate narcology and HIV systems of care using elements shown to facilitate engagement in medical care: HIV case management and point-of-care CD4 testing. The central hypothesis is that an intervention that involves coordination between the narcology and HIV systems via HIV case management delivered by a peer to help motivate and reduce barriers to HIV care will lead to engagement in HIV care.
Implementation research recognizes that effective interventions may not translate successfully across different contexts and systems. Hence, we will assess the organizational and operational issues that drive engagement in HIV care in Russia.
The project will be undertaken by an international research team experienced in addressing HIV, substance use, and clinical interventions in Russia. This proposal's Specific Aims are to assess the effectiveness of the LINC intervention compared to standard of care on 4 distinct outcomes: 1) initiation of HIV care (> 1 visit to HIV medical care) within 6 months of enrollment; 2) retention in HIV care (> 1 visit to medical care in 2 consecutive 6 month periods) within 12 months; 3) appropriate HIV care (prescribed ART if CD4 cell count is <350 or having a second CD4 count if CD4 ≥350 within 12 months; and 4) improved HIV health outcomes (CD4 cell count at 12 months). The final Specific Aim is to establish the contextual factors that influence adoption and sustainability of the LINC intervention in Russia. If LINC can embed effectively within Eastern European medical systems, then it has the potential to be widely implemented in this region of the world and have a major impact on the HIV epidemic among IDUs.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
St. Petersburg, Den russiske føderasjonen
- City Addiction Hospital
-
St. Petersburg, Den russiske føderasjonen
- Pavlov State Medical University
-
St. Petersburg, Den russiske føderasjonen
- Botkin Infectious Disease Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- age 18 - 70 years
- HIV-infected
- hospitalized at a narcology hospital
- history of injection drug use
- available for CD4 testing
- has 2 contacts to assist with follow-up
- lives within 100 km of St. Petersburg, Russia
- has telephone
- willing to receive care at Botkin Infectious Disease Hospital
Exclusion Criteria:
- currently on ART
- not fluent in Russian
- cognitive impairment precluding informed consent
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: Standard of Care
Control participants will receive the narcology hospital's standard of care.
With regard to linkage to HIV medical care, patients will be given printed information about where to obtain HIV medical care - the outpatient clinic that is involved in the intervention.
Control patients will be referred to outpatient narcology care as part of standard of care.
If control participants are newly diagnosed with HIV infection at the addiction hospital, they will receive HIV post test counseling consistent with CDC recommendations (this represents an enhancement of the current standard of care in Russia).
|
|
Eksperimentell: LINC Case Management (Intervention)
LINC Case Management (study Intervention) - see Intervention description
|
The 1st case management (CM) session will be at the Narcology Hospital and will follow a modified strengths-based case management curriculum.
As part of this first session, the CM will show a 10 minute video clip produced by a Russian NGO of HIV-infected patients talking about accessing HIV care.
The CM will also tell the patient what his/her CD4 cell count is and discuss what it means with the patient.
The case manager will help the client identify the outpatient HIV clinic on a map and will discuss basic drug harm reduction ideas with the client.
The remaining 4 CM sessions will happen over the following 6 months.
Sessions may happen at the HIV clinic, NGOs, or in the community.
The HIV CM helps the client understand the importance of HIV care, identify barriers to care acquisition and recognize one's own strengths, abilities and assets to reduce self-identified barriers to care.
The HIV CM's primary aim is to have the client attend an appointment at the HIV outpatient clinic.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
1) initiation of HIV care
Tidsramme: 6 months
|
Greater than or equal to 1 visit to HIV medical care within 6 months of enrollment
|
6 months
|
2) retention in HIV care
Tidsramme: 12 months
|
Greater than or equal 1 visit to medical care in 2 consecutive 6 month periods within 12 months
|
12 months
|
3) appropriate HIV care
Tidsramme: 12 months
|
prescribed ART if CD4 cell count is less than 350 or having a second CD4 count if CD4 is greater than or equal to 350 within 12 months (Note: As guidelines change over time, this outcome may be updated accordingly.)
|
12 months
|
4) improved HIV health outcomes
Tidsramme: 12 months
|
CD4 cell count at 12 months (compared to CD4 cell count at baseline)
|
12 months
|
5) Establish the contextual factors that influence adoption and sustainability of the LINC intervention in Russia
Tidsramme: 4 years
|
Qualitative implementation science analysis, including pre-implementation focus groups, interviews, and surveys in Russia; post-implementation qualitative interviews in Russia.
|
4 years
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Jeffrey Samet, MD, MA, MPH, Boston Medical Center
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- H-30414
- R01DA032082 (U.S. NIH-stipend/kontrakt)
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på HIV-infeksjon
-
Universidad del DesarrolloFullførtHealthcare Associated InfectionChile
-
Imelda Hospital, BonheidenFullførtHealthcare Associated InfectionBelgia
-
Centre Hospitalier Universitaire de NīmesRekrutteringEldre | Healthcare Associated InfectionFrankrike
-
Centre Hospitalier Universitaire, AmiensFullførtHealthcare Associated Infection | IglerFrankrike
-
Johns Hopkins UniversityFullførtHealthcare Associated Infection | Multiresistente organismer
-
University of PennsylvaniaFullførtAntimikrobiell resistensForente stater, Botswana
-
University of Maryland, BaltimoreVA Office of Research and DevelopmentFullførtMenneskelig mikrobiomForente stater
-
Universidad Autonoma de Nuevo LeonUkjentHelsetilknyttede infeksjoner
-
Children's Hospital Medical Center, CincinnatiAvsluttetAllogen hematopoetisk celletransplantasjonForente stater
-
University of Colorado, DenverUniversity of IowaFullførtHealth Care Associated Infection | HåndhygieneForente stater
Kliniske studier på LINC Case Management
-
University of North Carolina, CharlotteNational Institute of Mental Health (NIMH)Har ikke rekruttert ennåSelvmord | SelvmordsforebyggingForente stater
-
University of SouthamptonTilbaketrukket
-
University of PittsburghFullførtHalspulsåren stenoseForente stater
-
Treatment Research InstituteNational Institute on Drug Abuse (NIDA)Fullført
-
University of WashingtonNational Institute on Drug Abuse (NIDA)Rekruttering
-
University of WashingtonNational Institute on Drug Abuse (NIDA)FullførtOpioidbruksforstyrrelse | AkuttmottakForente stater
-
Sichuan Provincial People's HospitalRekruttering
-
Soterix MedicalFullført
-
University of OxfordNHS Health Technology Assessment Programme; BUPA FoundationUkjentCarotis stenoseTyskland, Italia, Israel, Storbritannia, Kroatia, Sveits, Kina, Canada, Østerrike, Sverige, Spania, Belgia, Tsjekkia, Frankrike, Forente stater, Brasil, Bulgaria, Egypt, Estland, Hellas, Ungarn, Irland, Japan, Kasakhstan, Nederland, Norge, Polen og mer